Literature DB >> 8677215

Pharmacotherapy for chronic depression.

R A Friedman1, J H Kocsis.   

Abstract

There is now strong evidence from controlled studies that antidepressant medication, including SSRIs, tricyclic antidepressants, and MAOIs, is effective in treating both the depressive symptomatology and social dysfunction of many patients with chronic depression. Encouraging data from a controlled long-term trial in progress indicate that desipramine is effective in sustaining recovery during maintenance treatment. Future studies are needed to better understand the optimal duration of treatment, the efficacy of augmentation strategies, and the efficacy of combined treatment with psychotherapy and pharmacotherapy in chronic depression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8677215     DOI: 10.1016/s0193-953x(05)70277-x

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  3 in total

1.  A randomized controlled trial comparing moclobemide and moclobemide plus interpersonal psychotherapy in the treatment of dysthymic disorder.

Authors:  M F de Mello; L M Myczcowisk; P R Menezes
Journal:  J Psychother Pract Res       Date:  2001

2.  Chronic depression: a case series of 203 outpatients treated at a private practice.

Authors:  F Benazzi
Journal:  J Psychiatry Neurosci       Date:  1998-01       Impact factor: 6.186

3.  Revisiting the antidepressant-like effects of desipramine in male and female adult rats: sex disparities in neurochemical correlates.

Authors:  Sandra Ledesma-Corvi; M Julia García-Fuster
Journal:  Pharmacol Rep       Date:  2022-06-02       Impact factor: 3.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.